Psychedelics Today, Author at PsyNews.com

Home Authors Posts by Watertime

404 POSTS 0 COMMENTS

Australia’s Largest Private Health Insurer Commits $10M to Fund MDMA Therapy...

Ibogaine and the Future of Healing: Trevor Millar & Jonathan Dickinson...

Accredited Entheogenic Seminary: Inside the Congregation for Sacred Practices with Paul...

Does Cannabis Research Deserve As Much Funding As Ibogaine Research?

May 2025 Psychedelic Patent Update: Gilgamesh Broadens Moat Around Lead Candidate...

Pα+ Psychedelic Bulletin #201: Dispatches from Prague and London; Texas Becomes...

Win 10 Groundbreaking Psychedelic Books – Our Giveaway with Inner Traditions!

Psychedelic Playhouse by District216

Psychedelic Bulletin #200: Can Czechia Deliver on Psilocybin Access? A Closer...

1...192021...41 Page 20 of 41

EDITOR PICKS

Psilocybin for OCD: Terence Ching on Lessons from Yale’s Randomised Trials

Pα+ Psychedelic Bulletin #220: New State Bills; Congressional Mentions; Published Psilocybin,...

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

Watertime

PS 25 Morning Show – Day One

Australia’s Largest Private Health Insurer Commits $10M to Fund MDMA Therapy...

Ibogaine and the Future of Healing: Trevor Millar & Jonathan Dickinson...

Accredited Entheogenic Seminary: Inside the Congregation for Sacred Practices with Paul...

Does Cannabis Research Deserve As Much Funding As Ibogaine Research?

May 2025 Psychedelic Patent Update: Gilgamesh Broadens Moat Around Lead Candidate...

Pα+ Psychedelic Bulletin #201: Dispatches from Prague and London; Texas Becomes...

Win 10 Groundbreaking Psychedelic Books – Our Giveaway with Inner Traditions!

Psychedelic Playhouse by District216

Psychedelic Bulletin #200: Can Czechia Deliver on Psilocybin Access? A Closer...

EDITOR PICKS

Psilocybin for OCD: Terence Ching on Lessons from Yale’s Randomised Trials

Pα+ Psychedelic Bulletin #220: New State Bills; Congressional Mentions; Published Psilocybin,...

Pα+ Psychedelic Bulletin #220: New State Bills; Congressional Mentions; Published Psilocybin,...

POPULAR POSTS

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

POPULAR CATEGORY